Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SYDNEY, AUSTRALIA--(Marketwired - Dec 11, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) today announces important progress in its collaboration with NEC Corporation and Yamaguchi University in...
-
SYDNEY, AUSTRALIA--(Marketwired - Nov 18, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) Highlights Prima to run a Phase I safety and dose finding study of...
-
SYDNEY, AUSTRALIA--(Marketwired - Oct 30, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), a leading immuno-oncology company, announces that it has raised A$2.0 million via an equity placement at...
-
SYDNEY, AUSTRALIA--(Marketwired - Oct 27, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) Belgium's Federal Agency for Medicines and Health Products Approved the...
-
SYDNEY, AUSTRALIA--(Marketwired - Oct 13, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, announces that it has raised EUR 1M...
-
SYDNEY, AUSTRALIA--(Marketwired - Sep 25, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company"), a leading immuno-oncology company, announces that Marc Voigt, CEO, will...
-
SYDNEY, AUSTRALIA--(Marketwired - Aug 14, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced it will receive an undisclosed clinical milestone payment...
-
SYDNEY, AUSTRALIA--(Marketwired - Jul 7, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, is pleased to announce that it has received...
-
SYDNEY, AUSTRALIA--(Marketwired - Jun 11, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, is pleased to announce that it has...
-
SYDNEY, AUSTRALIA--(Marketwired - Jun 4, 2015) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company"), announces that, further to the announcement made on 29 December 2014, it has...